These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1794133

  • 21. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
    Fowke JH, Shu XO, Dai Q, Jin F, Cai Q, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1308-15. PubMed ID: 15298951
    [Abstract] [Full Text] [Related]

  • 22. Oral contraceptive risks: a realistic appraisal.
    Bressler R, Durand JL.
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [Abstract] [Full Text] [Related]

  • 23. Epidemiology of oral contraceptives and the risk of breast cancer.
    Webster L.
    J Reprod Med; 1986 Jun; 31(6 Suppl):540-5. PubMed ID: 3723486
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Contraception and breast cancer].
    Kottler ML, Gorins A.
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):21-6. PubMed ID: 2068480
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Oral contraceptives and breast cancer: what has 20 years of research shown?
    Buehring GC.
    Biomed Pharmacother; 1988 Jan; 42(8):525-30. PubMed ID: 3066414
    [Abstract] [Full Text] [Related]

  • 32. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 33. [The pill and cancer of the breast and cervix uteri].
    Pedersen A.
    Ugeskr Laeger; 1984 Apr 02; 146(14):1063-6. PubMed ID: 6730039
    [Abstract] [Full Text] [Related]

  • 34. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia.
    Ravnihar B, Primic Zakelj M, Kosmelj K, Stare J.
    Neoplasma; 1988 Apr 02; 35(1):109-21. PubMed ID: 3352833
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pregnancy and lactation in relation to breast cancer risk.
    Vorherr H.
    Semin Perinatol; 1979 Jul 02; 3(3):299-311. PubMed ID: 392771
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response.
    Huzell L, Persson M, Simonsson M, Markkula A, Ingvar C, Rose C, Jernström H.
    Breast Cancer Res Treat; 2015 Jan 02; 149(2):505-15. PubMed ID: 25556354
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.